Source: Pharmacy Times articles
Rilonacept offers a targeted approach to treating recurrent pericarditis by blocking IL-1 inflammatory pathways.
Read More
by MM360 Staff | Jun 6, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Rilonacept offers a targeted approach to treating recurrent pericarditis by blocking IL-1 inflammatory pathways.
Read More